APA

Papp K. A., Yang M., Sundaram M., Jarvis J., Betts K. A., Bao Y. & Signorovitch J. E. (20180423). Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized Trials. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Chicago

Papp Kim A, Yang Min, Sundaram Murali, Jarvis John, Betts Keith A, Bao Yanjun and Signorovitch James E. 20180423. Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized Trials. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Harvard

Papp K. A., Yang M., Sundaram M., Jarvis J., Betts K. A., Bao Y. and Signorovitch J. E. (20180423). Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized Trials. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

MLA

Papp Kim A, Yang Min, Sundaram Murali, Jarvis John, Betts Keith A, Bao Yanjun and Signorovitch James E. Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized Trials. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 20180423.